Open Peer Commentary to "Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019"

Alzheimers Dement. 2021 Apr;17(4):702-703. doi: 10.1002/alz.12235. Epub 2020 Nov 1.

Authors

Marwan Noel Sabbagh¹, Jeffrey Cummings^{1

2}

Affiliations

¹ Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
² Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, USA.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Alzheimer Disease*
Antibodies, Monoclonal, Humanized*
Humans

Substances

Antibodies, Monoclonal, Humanized
aducanumab

Grants and funding